Dr. Keri Maher
Claim this profileVirginia Commonwealth University/Massey Cancer Center
Studies Acute Myeloid Leukemia
Studies Acute Myelogenous Leukemia
19 reported clinical trials
45 drugs studied
Area of expertise
1Acute Myeloid Leukemia
TP53 positive
FLT3 positive
Stage I
2Acute Myelogenous Leukemia
TP53 positive
FLT3 positive
Stage I
Affiliated Hospitals
Clinical Trials Keri Maher is currently running
Venetoclax + HMA
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial compares the usual treatment of azacitidine and venetoclax to the combination treatment of azacitidine, venetoclax and gilteritinib in treating older and unfit patients with acute myeloid leukemia and FLT3 mutations. Azacitidine is a drug that is absorbed into DNA and leads to the activation of cancer suppressor genes, which are genes that help control cell growth. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Gilteritinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This study may help doctors find out if these different approaches are better than the usual approaches. To decide if they are better, the study doctors are looking to see if the study drugs lead to a higher percentage of patients achieving a deeper remission compared to the usual approach.
Recruiting1 award Phase 27 criteria
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
More about Keri Maher
Clinical Trial Related2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Keri Maher has experience with
- Cytarabine
- Daunorubicin Hydrochloride
- Inotuzumab Ozogamicin
- Venetoclax
- Selinexor
- Dexamethasone
Breakdown of trials Keri Maher has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Myelodysplastic Syndrome
Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Keri Maher specialize in?
Keri Maher focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved TP53 positive patients, or patients who are FLT3 positive.
Is Keri Maher currently recruiting for clinical trials?
Yes, Keri Maher is currently recruiting for 7 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Keri Maher has studied deeply?
Yes, Keri Maher has studied treatments such as Cytarabine, Daunorubicin Hydrochloride, Inotuzumab Ozogamicin.
What is the best way to schedule an appointment with Keri Maher?
Apply for one of the trials that Keri Maher is conducting.
What is the office address of Keri Maher?
The office of Keri Maher is located at: Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia 23298 United States. This is the address for their practice at the Virginia Commonwealth University/Massey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.